JAMA & Archives
SEARCH
GO TO ADVANCED SEARCH
-
HOME  SUBSCRIPTIONS  E-MAIL ALERTS  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP

Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 341-350 of 550 total displayed.

Past content

Arch Dermatol
Correspondence
Omega-3 Fatty Acids and Acne—Reply
Loren Cordain
Arch Dermatol 2003; 139: 942-943. [Extract] [Full text] [PDF]  

Arch Intern Med
Original Investigations
Cholesterol-Lowering Effect of a Theaflavin-Enriched Green Tea Extract: A Randomized Controlled Trial
David J. Maron; Guo Ping Lu; Nai Sheng Cai; Zong Gui Wu; Yue Hua Li; Hui Chen; Jian Qiu Zhu; Xue Juan Jin; Bert C. Wouters; Jian Zhao
Arch Intern Med 2003; 163: 1448-1453. [Abstract] [Full text] [PDF]  

JAMA
Original Contributions
Impact of HIV Infection and HAART on Serum Lipids in Men
Sharon A. Riddler; Ellen Smit; Stephen R. Cole; Rui Li; Joan S. Chmiel; Adrian Dobs; Frank Palella; Barbara Visscher; Rhobert Evans; Lawrence A. Kingsley
JAMA 2003; 289: 2978-2982. [Abstract] [Full text] [PDF]  

Arch Intern Med
Review Articles
Interactions Between the Renin-Angiotensin System and Dyslipidemia: Relevance in the Therapy of Hypertension and Coronary Heart Disease
Balkrishna M. Singh; Jawahar L. Mehta
Arch Intern Med 2003; 163: 1296-1304. [Abstract] [Full text] [PDF]  

Arch Intern Med
Original Investigations
Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study
Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W. F. Wilson; Douglas P. Kiel; Michael Tocco; Ralph B. D'Agostino; Philip A. Wolf
Arch Intern Med 2003; 163: 1053-1057. [Abstract] [Full text] [PDF]  

Arch Intern Med
Original Investigations
Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus
Monika Safford; Laura Eaton; Gerald Hawley; Michael Brimacombe; Mangala Rajan; Huiling Li; Leonard Pogach
Arch Intern Med 2003; 163: 922-928. [Abstract] [Full text] [PDF]  

JAMA
Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Christopher R. Palmer; Morris J. Brown; Giuseppe Mancia; Luis M. Ruilope
JAMA 2003; 289: 2066-b-2067-b. [Extract] [Full text] [PDF]  

JAMA
Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Jan Laws Houghton
JAMA 2003; 289: 2066-a. [Extract] [Full text] [PDF]  

JAMA
Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Taishiro Chikamori
JAMA 2003; 289: 2066. [Extract] [Full text] [PDF]  

JAMA
Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Franz H. Messerli; Michael A. Weber
JAMA 2003; 289: 2067-2068. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55

 Collections
 •Topic Collections Home
 •Related collections:
  •Nutritional and Metabolic Disorders
  •Lipids and Lipid Disorders
  •Malabsorption Syndromes
  •Metabolic Diseases
  •Metabolism
  •Nutrition/ Malnutrition
  •Nutritional and Metabolic Disorders, Other
Advertisement




HOME | SUBSCRIPTIONS | E-MAIL ALERTS | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.